BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 33430825)

  • 1. The microbiologic spectrum of dacryocystitis.
    Luo B; Li M; Xiang N; Hu W; Liu R; Yan X
    BMC Ophthalmol; 2021 Jan; 21(1):29. PubMed ID: 33430825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The microbiologic spectrum of dacryocystitis: a national study of acute versus chronic infection.
    Mills DM; Bodman MG; Meyer DR; Morton AD;
    Ophthalmic Plast Reconstr Surg; 2007; 23(4):302-6. PubMed ID: 17667103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacteriological study of dacryocystitis among patients attending in Menelik II Hospital, Addis Ababa, Ethiopia.
    Kebede A; Adamu Y; Bejiga A
    Ethiop Med J; 2010 Jan; 48(1):29-33. PubMed ID: 20607995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute dacryocystitis in pediatric patients and frequency of nasolacrimal duct patency.
    Alaboudi A; Al-Shaikh O; Fatani D; Alsuhaibani AH
    Orbit; 2021 Feb; 40(1):18-23. PubMed ID: 31994430
    [No Abstract]   [Full Text] [Related]  

  • 5. Bacteriology and antibiotic therapy in congenital nasolacrimal duct obstruction.
    Kuchar A; Lukas J; Steinkogler FJ
    Acta Ophthalmol Scand; 2000 Dec; 78(6):694-8. PubMed ID: 11167236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative bacteriological profile and antibiogram of dacryocystitis.
    Shah CP; Santani D
    Nepal J Ophthalmol; 2011; 3(2):134-9. PubMed ID: 21876586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The microbiologic profile of dacryocystitis.
    Chung SY; Rafailov L; Turbin RE; Langer PD
    Orbit; 2019 Feb; 38(1):72-78. PubMed ID: 29750587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spectrum and the susceptibilities of microbial isolates in cases of congenital nasolacrimal duct obstruction.
    Usha K; Smitha S; Shah N; Lalitha P; Kelkar R
    J AAPOS; 2006 Oct; 10(5):469-72. PubMed ID: 17070485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pediatric Acute Dacryocystitis.
    Ali MJ
    Ophthalmic Plast Reconstr Surg; 2015; 31(5):341-7. PubMed ID: 25856337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbiological spectrum of microbial keratitis in patients presenting with nasolacrimal duct obstruction.
    Sharma S; Sahu SK; Rath S; Mallick A; Sharma S; Das S
    Eur J Ophthalmol; 2021 Jul; 31(4):1720-1724. PubMed ID: 32615806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and microbiologic features of dacryocystitis-related orbital cellulitis.
    Wladis EJ; Shinder R; LeFebvre DR; Sokol JA; Boyce M
    Orbit; 2016 Oct; 35(5):258-61. PubMed ID: 27399840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicobacteriological study of chronic dacryocystitis in adults.
    Mandal R; Banerjee AR; Biswas MC; Mondal A; Kundu PK; Sasmal NK
    J Indian Med Assoc; 2008 May; 106(5):296-8. PubMed ID: 18839635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacteriology and antimicrobial susceptibility of adult chronic dacryocystitis.
    Chaudhary M; Bhattarai A; Adhikari SK; Bhatta DR
    Nepal J Ophthalmol; 2010; 2(2):105-13. PubMed ID: 21505526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical bacteriology of dacryocystitis in adults.
    Coden DJ; Hornblass A; Haas BD
    Ophthalmic Plast Reconstr Surg; 1993 Jun; 9(2):125-31. PubMed ID: 8323904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency of Bacterial Samples from Patients with Chronic Acquired Nasolacrimal Duct Obstruction.
    Shahraki K; Makateb A; Shirzadi K; Khosravifard K
    Med Arch; 2016 Dec; 70(6):433-436. PubMed ID: 28210015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changing bacterial isolates and antibiotic sensitivities of purulent dacryocystitis.
    Briscoe D; Rubowitz A; Assia E
    Orbit; 2005 Mar; 24(1):29-32. PubMed ID: 15764113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High Prevalence of Biofilm-Forming MRSA in the Conjunctival Flora in Chronic Dacryocystitis.
    Mitra S; Chayani N; Mohapatra D; Barik MR; Sharma S; Basu S
    Semin Ophthalmol; 2019; 34(2):74-79. PubMed ID: 30794029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changing bacterial isolates and antibiotic sensitivities of purulent dacryocystitis.
    Briscoe D; Rubowitz A; Assia EI
    Orbit; 2005 Jun; 24(2):95-8. PubMed ID: 16191795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Bacterial Etiology in the Tear Duct Infections Secondary to Congenital Nasolacrimal Duct Obstructions.
    Bekmez S; Eriş E; Altan EV; Dursun V
    J Craniofac Surg; 2019 Oct; 30(7):2214-2216. PubMed ID: 31369500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacteriology of lacrimal duct obstruction in adults.
    Hartikainen J; Lehtonen OP; Saari KM
    Br J Ophthalmol; 1997 Jan; 81(1):37-40. PubMed ID: 9135406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.